Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
To follow patent expirations for generic production purposes
— Pharmacist, Tunisia
To find drug patent expirations in the North Africa market
— Business development, India
To get information on when drug patents are set to expire or have expired
— Journalist, UK
To obtain the latest patent expiry data
— Pharmaceutical company sales director, Pakistan
For information about pharmaceutical patents
— Pharmacist, USA
Generated: May 25, 2017
| Patents: | 1 |
| Tradenames: | 8 |
| Ingredients: | 8 |
| NDAs: | 14 |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kvk Tech | PHENTERMINE HYDROCHLORIDE | phentermine hydrochloride | TABLET;ORAL | 040876-001 | Mar 31, 2008 | AA | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Kvk Tech | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | TABLET;ORAL | 040712-003 | Jul 31, 2006 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Kvk Tech | PHENTERMINE HYDROCHLORIDE | phentermine hydrochloride | CAPSULE;ORAL | 040886-001 | Mar 31, 2008 | AA | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Kvk Tech | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | TABLET;ORAL | 040712-002 | May 4, 2007 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Kvk Tech | HYDROXYZINE HYDROCHLORIDE | hydroxyzine hydrochloride | TABLET;ORAL | 040786-001 | Mar 20, 2007 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
To get information on drug patent expirations
— Analyst, USA
Updates on patents, new and expired; market watch on IP activities
— Formulation development scientist, India
To gain information on when to expect generics on the market in order to inform patients of when they can expect more affordable drugs
— Retail pharmacist, USA
To perform literature and patent searches
— Life science entrepreneur, USA
For Information on historical patent expiration of small molecules by formulation
— Life science strategy consulting, USA
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
